Clinical Supply Services for the Asia-Pacific Region – Catalent Pharma Solutions

Catalent’s strategic investment in its Asia-Pacific clinical supply network has been implemented in response to growing demand from local and multinational sponsors, and reflects the trend towards more sophisticated storage and handling needs, more frequent and larger global studies, and more efficient supply models, especially where expensive drugs or limited trial materials are available. Its expanded Singapore hub is GMP approved across all its activities, including secondary packaging, label printing, storage, distribution, returns and destruction management. In Japan, Catalent is to introduce clinical supply services at its 200,000 sq. ft. facility in Kakegawa. The facility will provide full service solutions, including project management and clinical supply management, comparator sourcing, secondary packaging and labelling, clinical storage, distribution, and drug return and destruction. Catalent’s Shanghai facility was the first in China to provide end-to-end clinical supply solutions, from clinical supply management, comparator/reference product sourcing and primary packaging, to clinical storage and distribution. In 2015, Catalent quadrupled cold chain capacity at the site, and installed dedicated receiving, dispatch and packaging areas. The Asian facilities integrate into Catalent’s global clinical supply network, enabling handling of a broad range of international compliance and distribution requirements and expedition of reliable clinical trials. www.catalent.com

---

---